Coloplast A/S (LON:0QBO)
London · Delayed Price · Currency is GBP · Price in DKK 489.00
+6.33 (1.31%)
At close: Feb 11, 2026
Coloplast Income Statement
Financials in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 27,891 | 27,874 | 27,030 | 24,500 | 22,579 | 19,426 | |
Revenue Growth (YoY) | 1.61% | 3.12% | 10.33% | 8.51% | 16.23% | 4.76% |
Cost of Revenue | 8,961 | 8,929 | 8,761 | 8,172 | 7,050 | 6,113 |
Gross Profit | 18,930 | 18,945 | 18,269 | 16,328 | 15,529 | 13,313 |
Selling, General & Admin | 10,440 | 10,420 | 10,069 | 8,633 | 7,802 | 6,247 |
Research & Development | 974 | 946 | 913 | 872 | 866 | 755 |
Other Operating Expenses | -141 | -140 | -22 | -25 | -56 | -48 |
Operating Expenses | 11,272 | 11,224 | 10,960 | 9,479 | 8,610 | 6,956 |
Operating Income | 7,658 | 7,721 | 7,309 | 6,849 | 6,919 | 6,357 |
Interest Expense | -713 | -753 | -795 | -638 | -172 | -25 |
Interest & Investment Income | 82 | 102 | 155 | 111 | 39 | 11 |
Currency Exchange Gain (Loss) | -307 | -231 | -218 | -178 | -134 | 114 |
Other Non Operating Income (Expenses) | -13 | -118 | -85 | -78 | -66 | -31 |
EBT Excluding Unusual Items | 6,707 | 6,721 | 6,366 | 6,066 | 6,586 | 6,426 |
Merger & Restructuring Charges | -39 | -78 | -89 | -118 | -171 | - |
Gain (Loss) on Sale of Assets | -49 | -49 | -23 | -3 | -7 | -4 |
Legal Settlements | - | - | - | -200 | -300 | -200 |
Other Unusual Items | -440 | -437 | 141 | 280 | 19 | 11 |
Pretax Income | 6,179 | 6,157 | 6,395 | 6,025 | 6,127 | 6,233 |
Income Tax Expense | 2,190 | 2,521 | 1,343 | 1,242 | 1,421 | 1,408 |
Net Income | 3,989 | 3,636 | 5,052 | 4,783 | 4,706 | 4,825 |
Net Income to Common | 3,989 | 3,636 | 5,052 | 4,783 | 4,706 | 4,825 |
Net Income Growth | -18.32% | -28.03% | 5.62% | 1.64% | -2.47% | 14.96% |
Shares Outstanding (Basic) | 225 | 225 | 225 | 215 | 213 | 213 |
Shares Outstanding (Diluted) | 225 | 225 | 225 | 216 | 213 | 213 |
Shares Change (YoY) | 0.17% | 0.22% | 4.36% | 1.27% | -0.19% | -0.05% |
EPS (Basic) | 17.70 | 16.13 | 22.46 | 22.21 | 22.15 | 22.67 |
EPS (Diluted) | 17.70 | 16.13 | 22.46 | 22.20 | 22.11 | 22.63 |
EPS Growth | -18.41% | -28.18% | 1.17% | 0.41% | -2.30% | 15.05% |
Free Cash Flow | 5,471 | 5,339 | 1,600 | 3,206 | 4,172 | 4,371 |
Free Cash Flow Per Share | 24.27 | 23.69 | 7.11 | 14.88 | 19.61 | 20.50 |
Dividend Per Share | 23.000 | 23.000 | 22.000 | 21.000 | 20.000 | 19.000 |
Dividend Growth | 4.54% | 4.54% | 4.76% | 5.00% | 5.26% | 5.56% |
Gross Margin | 67.87% | 67.97% | 67.59% | 66.64% | 68.78% | 68.53% |
Operating Margin | 27.46% | 27.70% | 27.04% | 27.96% | 30.64% | 32.72% |
Profit Margin | 14.30% | 13.04% | 18.69% | 19.52% | 20.84% | 24.84% |
Free Cash Flow Margin | 19.62% | 19.15% | 5.92% | 13.09% | 18.48% | 22.50% |
EBITDA | 8,584 | 8,630 | 8,191 | 7,568 | 7,544 | 6,897 |
EBITDA Margin | 30.78% | 30.96% | 30.30% | 30.89% | 33.41% | 35.50% |
D&A For EBITDA | 926 | 909 | 882 | 719 | 625 | 540 |
EBIT | 7,658 | 7,721 | 7,309 | 6,849 | 6,919 | 6,357 |
EBIT Margin | 27.46% | 27.70% | 27.04% | 27.96% | 30.64% | 32.72% |
Effective Tax Rate | 35.44% | 40.95% | 21.00% | 20.61% | 23.19% | 22.59% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.